Trials / Completed
CompletedNCT01081366
Drug Eluting Pantera Lux Catheter Registry
Evaluation of the Safety Profile of the Pantera Lux Paclitaxel Releasing Balloon for Coronary Arteries in Daily Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,064 (actual)
- Sponsor
- Biotronik AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
All comers registry - Evaluation of the safety and efficacy of the Pantera Lux Paclitaxel releasing balloon for coronary arteries in daily clinical practice.
Detailed description
All patients are treated with the Pantera Lux Paclitaxel releasing balloon. Clinical follow ups at 1, 6 and 12 months after coronary intervention.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-03-01
- Completion
- 2012-05-01
- First posted
- 2010-03-05
- Last updated
- 2016-01-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01081366. Inclusion in this directory is not an endorsement.